Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Viatris call volume above normal and directionally bullish » 11:05
01/27/23
01/27
11:05
01/27/23
11:05
VTRS

Viatris

$11.90 /

+0.27 (+2.32%)

Bullish option flow…

Bullish option flow detected in Viatris with 1,955 calls trading, 1.5x expected, and implied vol increasing almost 3 points to 29.20%. Feb-23 12 calls and Jan-24 15 calls are the most active options, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 0.16. Earnings are expected on February 27th.

ShowHide Related Items >><<
VTRS Viatris
$11.90 /

+0.27 (+2.32%)

VTRS Viatris
$11.90 /

+0.27 (+2.32%)

01/27/23 Jefferies
Viatris upgraded to Buy at Jefferies on increased visibility
01/27/23 Jefferies
Viatris upgraded to Buy from Hold at Jefferies
11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
VTRS Viatris
$11.90 /

+0.27 (+2.32%)

VTRS Viatris
$11.90 /

+0.27 (+2.32%)

VTRS Viatris
$11.90 /

+0.27 (+2.32%)

VTRS Viatris
$11.90 /

+0.27 (+2.32%)

Upgrade
Viatris upgraded to Buy at Jefferies on increased visibility » 07:43
01/27/23
01/27
07:43
01/27/23
07:43
VTRS

Viatris

$11.64 /

+ (+0.00%)

Jefferies analyst Glen…

Jefferies analyst Glen Santangelo upgraded Viatris to Buy from Hold with a price target of $15, up from $13, after management "laid out a clear roadmap and strategic update" in conjunction with Q3 results, closed the Biocon transaction was on November 29 and acquired two ophthalmology companies. The firm's updated estimates better reflect the impact from Biocon, recent M&A, planned non-core asset sales, business development and share repurchases and given the pro forma estimates for 2024, the pro forma valuation "paints a new picture," the analyst tells investors.

ShowHide Related Items >><<
VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

01/27/23 Jefferies
Viatris upgraded to Buy from Hold at Jefferies
11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

Upgrade
Viatris upgraded to Buy from Hold at Jefferies » 05:11
01/27/23
01/27
05:11
01/27/23
05:11
VTRS

Viatris

$11.64 /

+ (+0.00%)

Jefferies analyst Glen…

Jefferies analyst Glen Santangelo upgraded Viatris to Buy from Hold with a price target of $15, up from $13.

ShowHide Related Items >><<
VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

VTRS Viatris
$11.64 /

+ (+0.00%)

Tuesday
Options
Viatris put volume heavy and directionally bearish » 15:15
01/24/23
01/24
15:15
01/24/23
15:15
VTRS

Viatris

$11.66 /

-0.17 (-1.44%)

Bearish flow noted in…

Bearish flow noted in Viatris with 2,607 puts trading, or 1.6x expected. Most active are Feb-23 11.5 puts and Jan-24 12 puts, with total volume in those strikes near 1,800 contracts. The Put/Call Ratio is 1.76, while ATM IV is up nearly 3 points on the day. Earnings are expected on February 27th.

ShowHide Related Items >><<
VTRS Viatris
$11.66 /

-0.17 (-1.44%)

VTRS Viatris
$11.66 /

-0.17 (-1.44%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$11.66 /

-0.17 (-1.44%)

VTRS Viatris
$11.66 /

-0.17 (-1.44%)

VTRS Viatris
$11.66 /

-0.17 (-1.44%)

VTRS Viatris
$11.66 /

-0.17 (-1.44%)

Over a week ago
Options
Viatris call volume above normal and directionally bullish » 12:25
01/19/23
01/19
12:25
01/19/23
12:25
VTRS

Viatris

$11.42 /

-0.055 (-0.48%)

Bullish option flow…

Bullish option flow detected in Viatris with 7,126 calls trading, 4x expected, and implied vol increasing over 10 points to 39.72%. Feb-23 12 calls and 3/3 weekly 11.5 puts are the most active options, with total volume in those strikes near 6,100 contracts. The Put/Call Ratio is 0.19. Earnings are expected on February 27th.

ShowHide Related Items >><<
VTRS Viatris
$11.42 /

-0.055 (-0.48%)

VTRS Viatris
$11.42 /

-0.055 (-0.48%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$11.42 /

-0.055 (-0.48%)

VTRS Viatris
$11.42 /

-0.055 (-0.48%)

VTRS Viatris
$11.42 /

-0.055 (-0.48%)

VTRS Viatris
$11.42 /

-0.055 (-0.48%)

Options
Viatris call volume above normal and directionally bullish » 11:45
01/06/23
01/06
11:45
01/06/23
11:45
VTRS

Viatris

$12.05 /

+0.22 (+1.86%)

Bullish option flow…

Bullish option flow detected in Viatris with 7,965 calls trading, 6x expected, and implied vol increasing almost 5 points to 33.62%. Feb-23 13 calls and Feb-23 12 calls are the most active options, with total volume in those strikes near 6,100 contracts. The Put/Call Ratio is 0.07. Earnings are expected on February 27th.

ShowHide Related Items >><<
VTRS Viatris
$12.05 /

+0.22 (+1.86%)

VTRS Viatris
$12.05 /

+0.22 (+1.86%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$12.05 /

+0.22 (+1.86%)

VTRS Viatris
$12.05 /

+0.22 (+1.86%)

VTRS Viatris
$12.05 /

+0.22 (+1.86%)

VTRS Viatris
$12.05 /

+0.22 (+1.86%)

Options
Viatris call volume above normal and directionally bullish » 11:45
01/04/23
01/04
11:45
01/04/23
11:45
VTRS

Viatris

$11.65 /

+0.265 (+2.33%)

Bullish option flow…

Bullish option flow detected in Viatris with 1,843 calls trading, 1.4x expected, and implied vol increasing over 5 points to 32.64%. Jan-23 11 calls and Jan-23 10 puts are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.61. Earnings are expected on February 27th.

ShowHide Related Items >><<
VTRS Viatris
$11.65 /

+0.265 (+2.33%)

VTRS Viatris
$11.65 /

+0.265 (+2.33%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$11.65 /

+0.265 (+2.33%)

VTRS Viatris
$11.65 /

+0.265 (+2.33%)

VTRS Viatris
$11.65 /

+0.265 (+2.33%)

VTRS Viatris
$11.65 /

+0.265 (+2.33%)

Over a month ago
Options
Viatris put volume heavy and directionally bearish » 12:55
12/27/22
12/27
12:55
12/27/22
12:55
VTRS

Viatris

$11.02 /

+ (+0.00%)

Bearish flow noted in…

Bearish flow noted in Viatris with 2,061 puts trading, or 1.4x expected. Most active are 12/30 weekly 11 calls and 1/6 weekly 11 puts, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 1.51, while ATM IV is up nearly 18 points on the day. Earnings are expected on February 27th.

ShowHide Related Items >><<
VTRS Viatris
$11.02 /

+ (+0.00%)

VTRS Viatris
$11.02 /

+ (+0.00%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$11.02 /

+ (+0.00%)

VTRS Viatris
$11.02 /

+ (+0.00%)

VTRS Viatris
$11.02 /

+ (+0.00%)

VTRS Viatris
$11.02 /

+ (+0.00%)

Hot Stocks
Viatris says emissions reduction targets approved by SBTi » 09:04
12/14/22
12/14
09:04
12/14/22
09:04
VTRS

Viatris

$11.33 /

+0.195 (+1.75%)

Viatris announced that…

Viatris announced that its near-term science-based emissions reduction targets have been approved by the Science Based Targets initiative. SBTi is a global body enabling businesses to set ambitious emissions reduction targets in line with the latest climate science. Viatris announced its initial companywide sustainability goals, including environmental targets, earlier this year. The SBTi classified Viatris' scope 1 and 2 target ambition and has determined that it is in line with a 1.5 degrees C trajectory, a worldwide goal of limiting global warming. The company's climate targets are: Viatris commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2020 base year. Viatris Inc. also commits to reduce absolute scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and energy related activities, and upstream transportation and distribution 25% within the same timeframe.

ShowHide Related Items >><<
VTRS Viatris
$11.33 /

+0.195 (+1.75%)

VTRS Viatris
$11.33 /

+0.195 (+1.75%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$11.33 /

+0.195 (+1.75%)

VTRS Viatris
$11.33 /

+0.195 (+1.75%)

VTRS Viatris
$11.33 /

+0.195 (+1.75%)

VTRS Viatris
$11.33 /

+0.195 (+1.75%)

Hot Stocks
Calliditas Therapeutics enters exclusive Nefecon license agreement with Viatris » 05:16
12/13/22
12/13
05:16
12/13/22
05:16
CALT

Calliditas Therapeutics

$18.67 /

+0.67 (+3.72%)

, VTRS

Viatris

$11.14 /

+0.36 (+3.34%)

Calliditas Therapeutics…

Calliditas Therapeutics (CALT) announced that they have entered into an exclusive license agreement with Viatris (VTRS), to register and commercialize Nefecon, a specialty drug recently approved in Europe and the U.S. for the treatment of the chronic autoimmune kidney disease Immunoglobulin A Nephropathy, or IgAN, in Japan. Under the terms of the agreement, Calliditas is entitled receive an initial upfront payment of $20M upon signing and up to an additional $80M in pre-defined development and commercialization milestones. Viatris will also pay mid-teens percentage royalties on net sales. IgAN, also known as Berger's disease, is a rare and serious progressive autoimmune disease in which up to 50% of patients end up at risk of developing end stage renal disease and thus requiring dialysis or a kidney transplant.

ShowHide Related Items >><<
VTRS Viatris
$11.14 /

+0.36 (+3.34%)

CALT Calliditas Therapeutics
$18.67 /

+0.67 (+3.72%)

CALT Calliditas Therapeutics
$18.67 /

+0.67 (+3.72%)

06/16/22 Kepler Cheuvreux
Calliditas Therapeutics initiated with a Buy at Kepler Cheuvreux
06/02/22 Pareto
Calliditas Therapeutics initiated with a Buy at Pareto
03/15/22 Citi
Calliditas Therapeutics price target lowered to $76 from $84 at Citi
12/20/21 H.C. Wainwright
Calliditas price target raised to $62 from $52 at H.C. Wainwright
VTRS Viatris
$11.14 /

+0.36 (+3.34%)

11/09/22 UBS
Viatris upgraded to Neutral from Sell at UBS
11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/08/22 Piper Sandler
Viatris upgraded to Neutral after acquisitions at Piper Sandler
11/07/22 Piper Sandler
Viatris upgraded to Neutral from Underweight at Piper Sandler
VTRS Viatris
$11.14 /

+0.36 (+3.34%)

VTRS Viatris
$11.14 /

+0.36 (+3.34%)

VTRS Viatris
$11.14 /

+0.36 (+3.34%)

VTRS Viatris
$11.14 /

+0.36 (+3.34%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.